Insider · CIK 0001629794
New Enterprise Associates 15, L.P.
ownerdirector
Files at NEUE (NeueHealth, Inc.), SNTI (Senti Biosciences, Inc.). First filing Oct 6, 2025, latest Oct 6, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1,890 sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stock | +189,195 | $0.01 | $1,892 | 1,527,217 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stock | -280 | $6.75 | $1,890 | 1,526,937 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stock | +434,297 | $0.01 | $4,343 | 1,961,234 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stock | -643 | $6.75 | $4,340 | 1,960,591 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stock | -1,960,591 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivative | -189,195 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivative | +434,297 | - | - | 434,297 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivative | -434,297 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Mar 10, 2025 | SNTI Senti Biosciences, Inc. | CConversion Common Stock | +3,333,000 | - | - | 3,775,615 | Mar 12, 2025 |
| Mar 10, 2025 | SNTI Senti Biosciences, Inc. | CConversion Series A Convertible Preferred Stockderivative | -3,333 | - | - | 0 | Mar 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.